Clinical trial
Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes
NCT00067626 · Griffin Hospital, Other · Completed
Key facts
| NCT number | NCT00067626 |
|---|---|
| Title | Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes |
| Official title | Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes |
| Lead sponsor | Griffin Hospital, Other |
| Collaborators | National Center for Complementary and Integrative Health (NCCIH) NIH Yale University |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obesity, Pre-diabetes, Insulin Resistance, Impaired Glucose Tolerance, Impaired Fasting Glucose |
| Intervention type | Dietary Supplement |
| Interventions | Chromium |
| Enrollment | 60 |
| Start date | Apr 1, 2005 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Aug 26, 2003 |
| Last update posted | Oct 15, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: